Yuancheng Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuancheng Wu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Bo Li
Spine Center Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China
1 shared publication Daoli Xie
Hearing and Speech Rehabilitation Institute, College of Special Education, Binzhou Medical University, Yantai, China
1 shared publication- Dehuan Yang
School of Architecture and Transportation Engineering, Guilin University of Electronic Technology, Guilin 541004, China
1 shared publication - Hao Tang1 shared publication
Helen Molteni
Hearing and Speech Rehabilitation Institute, College of Special Education, Binzhou Medical University, Yantai, China
1 shared publication- Hongfei Yu1 shared publication
Latest Publications
- 20 June 2023
- Published by Elsevier in International Journal of Hydrogen Energy
- Vol. 48 (93) , 36327-36339
Isotropic compression behavior for methane hydrate-bearing soil with varying temperature and pore pressure
- 20 June 2023
- Published by Elsevier in International Journal of Hydrogen Energy
- Vol. 48 (93) , 36327-36339
Isotropic compression behavior for methane hydrate-bearing soil with varying temperature and pore pressure
- Open Access
- 28 January 2022
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 15, 753369
Autophagy Contributes to the Rapamycin-Induced Improvement of Otitis Media
Otitis media (OM) is a pervasive disease that involves hearing loss and severe complications. In our previous study, we successfully established a mouse model of human OM using Tlr2tm1Kir (TLR2–/–) mice with middle ear (ME) inoculation of streptococcal peptidoglycan-polysaccharide (PGPS). In this study, we found that hearing loss and OM infections in OM mice were significantly alleviated after treatment with rapamycin (RPM), a widely used mechanistic target of RPM complex 1 (mTORC1) inhibitor and autophagy inducer. First of all, we tested the activity of mTORC1 by evaluating p-S6, Raptor, and mTOR protein expression. The data suggested that the protein expression level of p-S6, Raptor and mTOR are decreased in TLR2–/– mice after the injection of PGPS. Furthermore, our data showed that both the autophagosome protein LC3-II, Beclin-1, ATG7, and autophagy substrate protein p62 accumulated at higher levels in mice with OM than in OM-negative mice. The expression of lysosomal-associated proteins LAMP1, Cathepsin B, and Cathepsin D increased in the OM mice compared with OM-negative mice. Rab7 and Syntaxin 17, which is necessary for the fusion of autophagosomes with lysosomes, are reduced in the OM mice. In addition, data also described that the protein expression level of p-S6, mTOR and Raptor are lower than PGPS group after RPM treatment. The accumulation of LC3-II, Beclin-1, and ATG7 are decreased, and the expression of Rab7 and Syntaxin 17 are increased significantly after RPM treatment. Our results suggest that autophagy impairment is involved in PGPS-induced OM and that RPM improves OM at least partly by relieving autophagy impairment. Modulating autophagic activity by RPM may be a possible effective treatment strategy for OM.
- 28 January 2022
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 15, 753369
Open AccessAutophagy Contributes to the Rapamycin-Induced Improvement of Otitis Media
Otitis media (OM) is a pervasive disease that involves hearing loss and severe complications. In our previous study, we successfully established a mouse model of human OM using Tlr2tm1Kir (TLR2–/–) mice with middle ear (ME) inoculation of streptococcal peptidoglycan-polysaccharide (PGPS). In this study, we found that hearing loss and OM infections in OM mice were significantly alleviated after treatment with rapamycin (RPM), a widely used mechanistic target of RPM complex 1 (mTORC1) inhibitor and autophagy inducer. First of all, we tested the activity of mTORC1 by evaluating p-S6, Raptor, and mTOR protein expression. The data suggested that the protein expression level of p-S6, Raptor and mTOR are decreased in TLR2–/– mice after the injection of PGPS. Furthermore, our data showed that both the autophagosome protein LC3-II, Beclin-1, ATG7, and autophagy substrate protein p62 accumulated at higher levels in mice with OM than in OM-negative mice. The expression of lysosomal-associated proteins LAMP1, Cathepsin B, and Cathepsin D increased in the OM mice compared with OM-negative mice. Rab7 and Syntaxin 17, which is necessary for the fusion of autophagosomes with lysosomes, are reduced in the OM mice. In addition, data also described that the protein expression level of p-S6, mTOR and Raptor are lower than PGPS group after RPM treatment. The accumulation of LC3-II, Beclin-1, and ATG7 are decreased, and the expression of Rab7 and Syntaxin 17 are increased significantly after RPM treatment. Our results suggest that autophagy impairment is involved in PGPS-induced OM and that RPM improves OM at least partly by relieving autophagy impairment. Modulating autophagic activity by RPM may be a possible effective treatment strategy for OM.